Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Timing of Rehabilitation After Cervical Spine Surgery in Degenerative Myelopathy

Official title: Feasibility of Early Post-operative Rehabilitation Following Cervical Spinal Surgery in Degenerative Myelopathy

Run by University of Alberta · NCT07636135 · Data updated 2026-11-12

This study tests whether starting physical therapy two weeks after cervical spine surgery helps people with degenerative cervical myelopathy recover better than starting at six weeks.

More Cervical Myelopathy trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity of Alberta
Academic / other
Locations1 site (Edmonton, Alberta)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedOctober 31, 2027
Study endsDecember 31, 2027
Registry record updatedAugust 7, 2026
Trial IDNCT07636135 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with degenerative cervical myelopathy having decompression surgery, able to stand with minimal assistance and discharged home to attend 8 weeks of in-person rehab in Edmonton.

Probably not a fit

People unable to attend in-person rehabilitation in Edmonton or those with complications delaying discharge may not benefit from earlier rehabilitation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with degenerative cervical myelopathy undergoing cervical spine surgery are randomized to begin rehabilitation either two weeks or six weeks after surgery. All participants receive twice-weekly physical therapy for eight weeks focusing on strength, balance, and walking, with assessments of walking, balance, activity, quality of life, and nervous system function. The trial aims to determine feasibility, acceptability, and whether earlier rehabilitation improves functional outcomes and participation after surgery. It is conducted at the University of Alberta in Edmonton, with collaboration from the Alberta Spine Foundation. Participants must be able to attend in-person rehab and be discharged home after surgery.

Why it matters

Potential benefit: If earlier rehabilitation proves beneficial, patients may regain mobility and daily function sooner after surgery.

How similar studies have gone: Prior research in post-operative rehab supports the potential value of earlier rehabilitation, but this precise timing comparison is novel for degenerative cervical myelopathy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adult (\>18 years of age) with diagnosis of degenerative cervical myelopathy, within 2 weeks of spinal decompression surgery
* plan to be discharged home from acute care (i.e., not admitted to another facility for post-operative rehabilitation)
* able to stand with a maximum of one-person assist (+/- use of gait aid)
* persistent functional impairment in lower extremity strength, balance, coordination, and/or gait
* ability to attend an 8-week in-person rehabilitation program in Edmonton, Alberta

Exclusion Criteria:

* discharge from acute care facility \> 2 weeks post-operative
* intra-operative or early post-operative complication delaying discharge or precluding participation in early rehabilitation

Where it's running

  • University of Alberta
    Edmonton, Alberta, Canada
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.